Invirsa
Manufacturing · Ohio, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1275 Kinnear Rd, Columbus, Ohio, 43212, ...Phone Number
(614) 715-1860Website
www.invirsa.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Invirsa
Invirsa is a biotechnology company focused on developing innovative treatments for ocular conditions associated with DNA damage, particularly through their lead compound INV-102. Their primary target clients include patients suffering from ocular injuries due to sulfur mustard gas and those with diabetic dry eye, a condition that is more severe in diabetic populations. The company has secured a partnership with BARDA to support the development of INV-102, aiming to provide disease-modifying therapeutic options rather than just symptomatic relief. Invirsa's leadership team employs a unique approach to drug development, leveraging extensive knowledge to address significant pharmaceutical challenges.Explore more
Invirsa Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Invirsa your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Invirsa
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Invirsa has new funding data
Product Launch: Get notified when Invirsa launches new products
Earning: See what the market has to say on Invirsa recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Invirsa is spiking on competitors!
Check if Invirsa has recently received funding, and reach out quickly before it becomes old news!
Invirsa, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Invirsa had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Invirsa
Compare insights from companies similar to Invirsa, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Invirsa
<$5M
11-50
Private
$10.5M
2016
JR
Jared RandallSenior Director, Chemistry, Manufacturing & Controls
Company Profile Activity
Activity Insights
Invirsa is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Invirsa is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Invirsa.
Invirsa financials insights
Gather financial insights about Invirsa, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series B
$7.7M
2025
Private Equity
$2.8M
Invirsa Tech Stack
A closer look at the technologies used by Invirsa
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Executive Move
Invirsa has announced that Phillip Casteel has been appointed as Chief Financial Officer.
Executive Moves
Executive Move
Executive Moves
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Invirsa
Sign Up For FreeTo access detailed company insights
Invirsa is a biotechnology company focused on developing innovative treatments for ocular conditions associated with DNA damage, particularly through their lead compound INV-102. Their primary target clients include patients suffering from ocular injuries due to sulfur mustard gas and those with diabetic dry eye, a condition that is more severe in... Read More
